Cargando…

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy

Detalles Bibliográficos
Autores principales:	Dai, Xiangpeng, Zhang, Jinfang, North, Brian J., Guo, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413158/ https://www.ncbi.nlm.nih.gov/pubmed/36032068 http://dx.doi.org/10.3389/fimmu.2022.1006145

Ejemplares similares

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II
por: Nihira, Naoe Taira, et al.
Publicado: (2023)

Advances in post-translational modifications of proteins and cancer immunotherapy
por: Li, Yanqing, et al.
Publicado: (2023)

Editorial: Targeting Protein Post-Translational Modifications (PTMs) for Diagnosis and Treatment of Sepsis
por: Chang, Panpan, et al.
Publicado: (2022)

Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responses
por: Afonina, Inna S., et al.
Publicado: (2022)

Post-translational modifications and immune responses in liver cancer
por: Wang, You-Wei, et al.
Publicado: (2023)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
por: Dai, Weijing, et al.
Publicado: (2022)

Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy
por: Feng, Chong, et al.
Publicado: (2023)

Post-Translational Modifications of Exosomal Proteins
por: Moreno-Gonzalo, Olga, et al.
Publicado: (2014)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

Editorial: Translational phenomics and its applications in immunotherapy
por: Fang, Hai, et al.
Publicado: (2023)

Editorial: Structure, Isotypes, Targets, and Post-translational Modifications of Immunoglobulins and Their Role in Infection, Inflammation and Autoimmunity
por: Harb, Jean, et al.
Publicado: (2020)

Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy
por: Gu, Xu, et al.
Publicado: (2023)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Oxidation is an underappreciated post-translational modification in the regulation of immune responses associated with changes in phosphorylation
por: Karkossa, Isabel, et al.
Publicado: (2023)

Editorial: Structure, isotypes, targets, and post-translational modifications of immunoglobulins and their role in infection, inflammation and autoimmunity, Volume II
por: Novak, Jan, et al.
Publicado: (2022)

Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways
por: Deng, Yu, et al.
Publicado: (2022)

Protein post-translational modification in SARS-CoV-2 and host interaction
por: Cheng, Nana, et al.
Publicado: (2023)

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Role of Histone Post-Translational Modifications in Inflammatory Diseases
por: Lin, Yingying, et al.
Publicado: (2022)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: Bacterial Post-translational Modifications
por: Carabetta, Valerie J., et al.
Publicado: (2022)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
por: Nunès, Jacques A., et al.
Publicado: (2023)

Foxp3 Post-translational Modifications and Treg Suppressive Activity
por: Deng, Guoping, et al.
Publicado: (2019)

Post-Translational Modifications of STING: A Potential Therapeutic Target
por: Kang, Jiaqi, et al.
Publicado: (2022)

Dysbiosis May Trigger Autoimmune Diseases via Inappropriate Post-Translational Modification of Host Proteins
por: Lerner, Aaron, et al.
Publicado: (2016)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
por: Tan, Ruirong, et al.
Publicado: (2023)

The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment
por: De Sanctis, Francesco, et al.
Publicado: (2014)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Editorial: Non-coding RNA in immunotherapies and immune regulation
por: Kaeffer, Bertrand, et al.
Publicado: (2022)

Editorial: Proteoglycans and Glycosaminoglycan Modification in Immune Regulation and Inflammation
por: Reijmers, Rogier M., et al.
Publicado: (2020)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cu850tiolki4rt9uth0qsmhk0g